 | • レポートコード：D0804-08962 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ニューロトロフィンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ニューロトロフィンの種類別市場規模（神経成長因子、脳由来神経栄養因子、硫酸デヒドロエピアンドロステロン、その他）、用途別市場規模（アルツハイマー病、筋萎縮性側索硬化症、パーキンソン病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Johnson＆Johnson、GE Healthcare、Scil Proteins GmbH、Lonza Groups、PeproTech、FibroGen、Scil Proteins GmbH、Merck Serono ・地域別グローバル市場分析 2015年-2020年 ・ニューロトロフィンの北米市場（アメリカ、カナダ、メキシコ） ・ニューロトロフィンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ニューロトロフィンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ニューロトロフィンの南米市場（ブラジル、アルゼンチン） ・ニューロトロフィンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：神経成長因子、脳由来神経栄養因子、硫酸デヒドロエピアンドロステロン、その他 ・用途別分析：アルツハイマー病、筋萎縮性側索硬化症、パーキンソン病、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Neurotrophins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Neurotrophins market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Neurotrophins market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neurotrophins market has been segmented into
Nerve Growth Factor
Brain-Derived Neurotrophic Factor
Dehydroepiandrosterone Sulfate
Other
By Application, Neurotrophins has been segmented into:
Alzheimer’S Disease
Amyotrophic Lateral Sclerosis
Parkinson’S Disease
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neurotrophins market presented in the report. This section sheds light on the sales growth of different regional and country-level Neurotrophins markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neurotrophins market.
The report offers in-depth assessment of the growth and other aspects of the Neurotrophins market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neurotrophins Market Share Analysis
Neurotrophins competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neurotrophins sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neurotrophins sales, revenue and market share for each player covered in this report.
The major players covered in Neurotrophins are:
Johnson＆Johnson
GE Healthcare
Scil Proteins GmbH
Lonza Groups
PeproTech
FibroGen
Scil Proteins GmbH
Merck Serono
Among other players domestic and global, Neurotrophins market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurotrophins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurotrophins, with price, sales, revenue and global market share of Neurotrophins in 2018 and 2019.
Chapter 3, the Neurotrophins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurotrophins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neurotrophins market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neurotrophins sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Neurotrophins Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neurotrophins Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Nerve Growth Factor
1.2.3 Brain-Derived Neurotrophic Factor
1.2.4 Dehydroepiandrosterone Sulfate
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Neurotrophins Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Alzheimer’S Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Parkinson’S Disease
1.3.5 Other
1.4 Overview of Global Neurotrophins Market
1.4.1 Global Neurotrophins Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson＆Johnson
2.1.1 Johnson＆Johnson Details
2.1.2 Johnson＆Johnson Major Business
2.1.3 Johnson＆Johnson SWOT Analysis
2.1.4 Johnson＆Johnson Product and Services
2.1.5 Johnson＆Johnson Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare SWOT Analysis
2.2.4 GE Healthcare Product and Services
2.2.5 GE Healthcare Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Scil Proteins GmbH
2.3.1 Scil Proteins GmbH Details
2.3.2 Scil Proteins GmbH Major Business
2.3.3 Scil Proteins GmbH SWOT Analysis
2.3.4 Scil Proteins GmbH Product and Services
2.3.5 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Lonza Groups
2.4.1 Lonza Groups Details
2.4.2 Lonza Groups Major Business
2.4.3 Lonza Groups SWOT Analysis
2.4.4 Lonza Groups Product and Services
2.4.5 Lonza Groups Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 PeproTech
2.5.1 PeproTech Details
2.5.2 PeproTech Major Business
2.5.3 PeproTech SWOT Analysis
2.5.4 PeproTech Product and Services
2.5.5 PeproTech Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 FibroGen
2.6.1 FibroGen Details
2.6.2 FibroGen Major Business
2.6.3 FibroGen Product and Services
2.6.4 FibroGen Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Scil Proteins GmbH
2.7.1 Scil Proteins GmbH Details
2.7.2 Scil Proteins GmbH Major Business
2.7.3 Scil Proteins GmbH Product and Services
2.7.4 Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck Serono
2.8.1 Merck Serono Details
2.8.2 Merck Serono Major Business
2.8.3 Merck Serono Product and Services
2.8.4 Merck Serono Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neurotrophins Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neurotrophins Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neurotrophins Manufacturer Market Share in 2019
3.3.2 Top 6 Neurotrophins Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neurotrophins Sales, Revenue and Market Share by Regions
4.1.1 Global Neurotrophins Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neurotrophins Revenue and Market Share by Regions (2015-2020)
4.2 North America Neurotrophins Sales and Growth Rate (2015-2020)
4.3 Europe Neurotrophins Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neurotrophins Sales and Growth Rate (2015-2020)
4.5 South America Neurotrophins Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neurotrophins Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neurotrophins Sales, Revenue and Market Share by Country
5.1.1 North America Neurotrophins Sales and Market Share by Country (2015-2020)
5.1.2 North America Neurotrophins Revenue and Market Share by Country (2015-2020)
5.2 United States Neurotrophins Sales and Growth Rate (2015-2020)
5.3 Canada Neurotrophins Sales and Growth Rate (2015-2020)
5.4 Mexico Neurotrophins Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neurotrophins Sales, Revenue and Market Share by Country
6.1.1 Europe Neurotrophins Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neurotrophins Revenue and Market Share by Country (2015-2020)
6.2 Germany Neurotrophins Sales and Growth Rate (2015-2020)
6.3 UK Neurotrophins Sales and Growth Rate (2015-2020)
6.4 France Neurotrophins Sales and Growth Rate (2015-2020)
6.5 Russia Neurotrophins Sales and Growth Rate (2015-2020)
6.6 Italy Neurotrophins Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neurotrophins Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neurotrophins Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neurotrophins Revenue and Market Share by Regions (2015-2020)
7.2 China Neurotrophins Sales and Growth Rate (2015-2020)
7.3 Japan Neurotrophins Sales and Growth Rate (2015-2020)
7.4 Korea Neurotrophins Sales and Growth Rate (2015-2020)
7.5 India Neurotrophins Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neurotrophins Sales and Growth Rate (2015-2020)
7.7 Australia Neurotrophins Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neurotrophins Sales, Revenue and Market Share by Country
8.1.1 South America Neurotrophins Sales and Market Share by Country (2015-2020)
8.1.2 South America Neurotrophins Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neurotrophins Sales and Growth Rate (2015-2020)
8.3 Argentina Neurotrophins Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neurotrophins Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neurotrophins Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neurotrophins Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neurotrophins Sales and Growth Rate (2015-2020)
9.3 Turkey Neurotrophins Sales and Growth Rate (2015-2020)
9.4 Egypt Neurotrophins Sales and Growth Rate (2015-2020)
9.5 South Africa Neurotrophins Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neurotrophins Sales and Market Share by Type (2015-2020)
10.2 Global Neurotrophins Revenue and Market Share by Type (2015-2020)
10.3 Global Neurotrophins Price by Type (2015-2020)
11 Global Neurotrophins Market Segment by Application
11.1 Global Neurotrophins Sales Market Share by Application (2015-2020)
11.2 Global Neurotrophins Revenue Market Share by Application (2015-2020)
11.3 Global Neurotrophins Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neurotrophins Sales, Revenue and Growth Rate (2021-2025)
12.2 Neurotrophins Market Forecast by Regions (2021-2025)
12.2.1 North America Neurotrophins Market Forecast (2021-2025)
12.2.2 Europe Neurotrophins Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neurotrophins Market Forecast (2021-2025)
12.2.4 South America Neurotrophins Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neurotrophins Market Forecast (2021-2025)
12.3 Neurotrophins Market Forecast by Type (2021-2025)
12.3.1 Global Neurotrophins Sales Forecast by Type (2021-2025)
12.3.2 Global Neurotrophins Market Share Forecast by Type (2021-2025)
12.4 Neurotrophins Market Forecast by Application (2021-2025)
12.4.1 Global Neurotrophins Sales Forecast by Application (2021-2025)
12.4.2 Global Neurotrophins Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neurotrophins Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neurotrophins by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neurotrophins Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Neurotrophins Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Johnson＆Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson＆Johnson Neurotrophins Major Business
Table 10. Johnson＆Johnson Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 11. Johnson＆Johnson SWOT Analysis
Table 12. Johnson＆Johnson Neurotrophins Product and Services
Table 13. Johnson＆Johnson Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 15. GE Healthcare Neurotrophins Major Business
Table 16. GE Healthcare Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 17. GE Healthcare SWOT Analysis
Table 18. GE Healthcare Neurotrophins Product and Services
Table 19. GE Healthcare Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Scil Proteins GmbH Basic Information, Manufacturing Base and Competitors
Table 21. Scil Proteins GmbH Neurotrophins Major Business
Table 22. Scil Proteins GmbH Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 23. Scil Proteins GmbH SWOT Analysis
Table 24. Scil Proteins GmbH Neurotrophins Product and Services
Table 25. Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Lonza Groups Basic Information, Manufacturing Base and Competitors
Table 27. Lonza Groups Neurotrophins Major Business
Table 28. Lonza Groups Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 29. Lonza Groups SWOT Analysis
Table 30. Lonza Groups Neurotrophins Product and Services
Table 31. Lonza Groups Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. PeproTech Basic Information, Manufacturing Base and Competitors
Table 33. PeproTech Neurotrophins Major Business
Table 34. PeproTech Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 35. PeproTech SWOT Analysis
Table 36. PeproTech Neurotrophins Product and Services
Table 37. PeproTech Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. FibroGen Basic Information, Manufacturing Base and Competitors
Table 39. FibroGen Neurotrophins Major Business
Table 40. FibroGen Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 41. FibroGen SWOT Analysis
Table 42. FibroGen Neurotrophins Product and Services
Table 43. FibroGen Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Scil Proteins GmbH Basic Information, Manufacturing Base and Competitors
Table 45. Scil Proteins GmbH Neurotrophins Major Business
Table 46. Scil Proteins GmbH Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 47. Scil Proteins GmbH SWOT Analysis
Table 48. Scil Proteins GmbH Neurotrophins Product and Services
Table 49. Scil Proteins GmbH Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 51. Merck Serono Neurotrophins Major Business
Table 52. Merck Serono Neurotrophins Total Revenue (USD Million) (2018-2019)
Table 53. Merck Serono SWOT Analysis
Table 54. Merck Serono Neurotrophins Product and Services
Table 55. Merck Serono Neurotrophins Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Neurotrophins Sales by Manufacturer (2018-2019) (K Units)
Table 57. Global Neurotrophins Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Neurotrophins Sales by Regions (2015-2020) (K Units)
Table 59. Global Neurotrophins Sales Market Share by Regions (2015-2020)
Table 60. Global Neurotrophins Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 62. North America Neurotrophins Sales Market Share by Countries (2015-2020)
Table 63. North America Neurotrophins Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Neurotrophins Revenue Market Share by Countries (2015-2020)
Table 65. Europe Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 66. Europe Neurotrophins Sales Market Share by Countries (2015-2020)
Table 67. Europe Neurotrophins Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Neurotrophins Sales by Regions (2015-2020) (K Units)
Table 69. Asia-Pacific Neurotrophins Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Neurotrophins Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 72. South America Neurotrophins Sales Market Share by Countries (2015-2020)
Table 73. South America Neurotrophins Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Neurotrophins Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Neurotrophins Sales by Countries (2015-2020) (K Units)
Table 76. Middle East & Africa Neurotrophins Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Neurotrophins Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Neurotrophins Revenue Market Share by Countries (2015-2020)
Table 79. Global Neurotrophins Sales by Type (2015-2020) (K Units)
Table 80. Global Neurotrophins Sales Share by Type (2015-2020)
Table 81. Global Neurotrophins Revenue by Type (2015-2020) (USD Million)
Table 82. Global Neurotrophins Revenue Share by Type (2015-2020)
Table 83. Global Neurotrophins Sales by Application (2015-2020) (K Units)
Table 84. Global Neurotrophins Sales Share by Application (2015-2020)
Table 85. Global Neurotrophins Sales Forecast by Regions (2021-2025) (K Units)
Table 86. Global Neurotrophins Market Share Forecast by Regions (2021-2025)
Table 87. Global Neurotrophins Sales Forecast by Type (2021-2025) (K Units)
Table 88. Global Neurotrophins Market Share Forecast by Type (2021-2025)
Table 89. Global Neurotrophins Sales Forecast by Application (2021-2025)
Table 90. Global Neurotrophins Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neurotrophins Picture
Figure 2. Global Sales Market Share of Neurotrophins by Type in 2019
Figure 3. Nerve Growth Factor Picture
Figure 4. Brain-Derived Neurotrophic Factor Picture
Figure 5. Dehydroepiandrosterone Sulfate Picture
Figure 6. Other Picture
Figure 7. Neurotrophins Sales Market Share by Application in 2019
Figure 8. Alzheimer'S Disease Picture
Figure 9. Amyotrophic Lateral Sclerosis Picture
Figure 10. Parkinson'S Disease Picture
Figure 11. Other Picture
Figure 12. Global Neurotrophins Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Neurotrophins Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Neurotrophins Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Neurotrophins Sales Market Share by Manufacturer in 2019
Figure 33. Global Neurotrophins Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Neurotrophins Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Neurotrophins Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Neurotrophins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Neurotrophins Revenue Market Share by Regions (2015-2020)
Figure 40. Global Neurotrophins Revenue Market Share by Regions in 2018
Figure 41. North America Neurotrophins Sales and Growth Rate (2015-2020)
Figure 42. Europe Neurotrophins Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Neurotrophins Sales and Growth Rate (2015-2020)
Figure 44. South America Neurotrophins Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Neurotrophins Sales and Growth Rate (2015-2020)
Figure 46. North America Neurotrophins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Neurotrophins Sales Market Share by Countries (2015-2020)
Figure 48. North America Neurotrophins Sales Market Share by Countries in 2018
Figure 49. North America Neurotrophins Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Neurotrophins Revenue Market Share by Countries in 2018
Figure 51. United States Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Neurotrophins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Neurotrophins Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Neurotrophins Revenue Market Share by Countries in 2019
Figure 57. Germany Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Neurotrophins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Neurotrophins Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Neurotrophins Revenue Market Share by Regions 2019
Figure 65. China Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Neurotrophins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Neurotrophins Sales Market Share by Countries in 2019
Figure 72. South America Neurotrophins Revenue Market Share by Countries in 2019
Figure 73. Brazil Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Neurotrophins Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Neurotrophins Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Neurotrophins Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Neurotrophins Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Neurotrophins Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Neurotrophins Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Neurotrophins Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Neurotrophins Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Neurotrophins Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Neurotrophins Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Neurotrophins Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Neurotrophins Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
注射用マウス神経成長因子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mouse Nerve Growth Factor for Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mouse…- パーキンソン病脳深部刺激・サービスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Deep Brain Stimulation and Service for Parkinson’s Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global mark…
- アルツハイマー病診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Alzheimer's Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer's Di…
- 認知症・アルツハイマー病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dementia and Alzheimer’s Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- 血液凝固因子の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Blood Coagulation Factor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood Coagulation Fa…